from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1905c/aao

LFCtreatmentdescriptionclass of inhibitor

-0.330

Amikacinug/mL Amikacintranslation

-0.052

Cap5-10ug/mL Capreomycintranslation

0.060

Rox10-50 ug/mL Roxithromycintranslation

-0.738

SM2-5 ug/mL Streptomycintranslation

0.886

Tet5-10 ug/mL Tetracyclinetranslation

-1.309

Rif0.2-5ug/mL Rifampicintranscription

-0.606

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.966

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.053

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.013

CPZ10-50 ug/mL Chlorpromazinerespiration

1.808

Clofazimine10-13 ug/mL Clofaziminerespiration

0.801

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.603

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.515

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.890

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.569

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.600

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.300

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.768

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.264

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.186

Nigericin50 uM Nigericinrespiration

-0.230

TRC10-150 ug/mL Triclosanrespiration

1.044

TRZ10-25 ug/mL Thioridazinerespiration

-0.627

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.208

menadione6-10 ug/mL Menadionerespiration

-0.387

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.406

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.282

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.126

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.750

NRP_1Non-replicating persistence stage 1dosRassociated

-0.302

Amp0.2mg/mL AmpicillincellWall

0.645

Cephalexin20-100 ug/mL CephalexincellWall

-0.873

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.446

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.492

EMB10-20 ug/mL EthambutolcellWall

-0.385

Eta12-40 ug/mL EthionamidecellWall

0.228

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.670

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.402

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.363

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.022

BZA0.12 mg/mL BenzamidearomaticAmides

0.128

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.845

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.038

H2O24 mM hydrogen peroxideDNAdamaging

0.168

Levo10 ug/mL LevofloxacinDNAdamaging

0.307

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.633

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.177

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.286

UVUV-irradiationDNAdamaging

0.707

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.354

Antimycin12.5-50 ug/mL Antimycin A?

-0.302

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.718

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.226

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.600

PA8240.2-2 ug/mL PA-824?

0.138

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.568

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.113

Verapamil50 uM Verapamil?

-0.195

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.744

methoxatin10-20 ug/mL Methoxatin?